Home > Insider Trading > Filing (0001209191-13-038645)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
887151	Capstone Therapeutics Corp.	CAPS	Pharmaceutical Preparations (2834)	860585310

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
949119	Iii I Lloyd Miller	222 Lakeview Avenue Suite 160-365 West Palm Beach FL 33401		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-07-30	1,139,000	$0.20	5,851,468	No	4	P	Indirect	By Trust A-4 - Lloyd I. Miller

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Trust A-4 - Lloyd I. Miller

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	472,792	Indirect	By Milfam II L.P.
Common Stock	90,344	Indirect	By Trust D - Lloyd I. Miller
Common Stock	545,462	Indirect	By Trust C - Lloyd I. Miller
Common Stock	95,756	Indirect	By Milgrat Q8
Common Stock	724,100	Indirect	By LIMFAM LLC
Common Stock	58,967	Direct

Footnotes

The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. This filing shall not be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owner of any equity securities covered by this filing.
On December 5, 2012, 545,462 securities held by Milgrat (Q8) were transferred to Trust C. Such transaction only effected a change in the form of beneficial ownership without changing the reporting person's pecuniary interest in such securities and was exempt from Section 16 of the Securities Exchange Act of 1934 pursuant to Rule 16a-13.